東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Biostatistics in biopharmaceutical r...

Chen, Ding-Geng.

Linked to FindBook

Google Book

Amazon

博客來

Biostatistics in biopharmaceutical research and development.. Volume 2,. Clinical trial analysis

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biostatistics in biopharmaceutical research and development./ edited by Ding-Geng Chen.
remainder title:	Clinical trial analysis
other author:	Chen, Ding-Geng.
Published:	Cham :Springer Nature Switzerland : : 2024.,
Description:	xviii, 517 p. :ill., digital ;24 cm.
[NT 15003449]:	Statistical Challenges in the Analysis of Biomarker Data -- 2. Evaluating Predictive Accuracy of Prognostic Model for Censored Time-to-Event Data Analysis in Clinical Trials -- Statistical Methods for Accommodating Immortal Time: A Selective Review and Comparison -- Variable selection for partially functional additive Cox Model with interval-censored failure time data -- A Bayesian proportional hazards model to predict patient recruitment in multicenter clinical trials -- GET MORE INFORMATION FROM RECURRENT EVENTS DATA -- Introduction to Patient Preference Studies -- Machine Learning for Precision Medicine and Humanized AI for Future Healthcare -- The Statistical Evaluation of Surrogate Endpoints in Clinical Trials -- Treatment Effect Estimation Using Data from Observational and Non-Randomized Studies -- Methods for Comparing Two Treatments for a Dichotomous Outcome for a Two-Period Design with Treatment Switching of Control Group Period 1 Non-Responders -- Regression-based estimation of optimal adaptive treatment strategies: Key methods -- Vaccine Disease-Prevention Efficacy Studies: Traditional Approaches and New Frontiers -- Covariate Adjustment in Analyzing Randomized Clinical Trials: Approaches, Software, and Application -- Joint correlated responses and feedback effect with time-dependent covariates -- Distributions and Their Approximations for P-Values.
Contained By:	Springer Nature eBook
Subject:	Clinical trials. -
Online resource:	https://doi.org/10.1007/978-3-031-65937-9
ISBN:	9783031659379

Biostatistics in biopharmaceutical research and development.. Volume 2,. Clinical trial analysis
Biostatistics in biopharmaceutical research and development.Volume 2,Clinical trial analysis[electronic resource] /Clinical trial analysisedited by Ding-Geng Chen. - Cham :Springer Nature Switzerland :2024. - xviii, 517 p. :ill., digital ;24 cm.

Statistical Challenges in the Analysis of Biomarker Data -- 2. Evaluating Predictive Accuracy of Prognostic Model for Censored Time-to-Event Data Analysis in Clinical Trials -- Statistical Methods for Accommodating Immortal Time: A Selective Review and Comparison -- Variable selection for partially functional additive Cox Model with interval-censored failure time data -- A Bayesian proportional hazards model to predict patient recruitment in multicenter clinical trials -- GET MORE INFORMATION FROM RECURRENT EVENTS DATA -- Introduction to Patient Preference Studies -- Machine Learning for Precision Medicine and Humanized AI for Future Healthcare -- The Statistical Evaluation of Surrogate Endpoints in Clinical Trials -- Treatment Effect Estimation Using Data from Observational and Non-Randomized Studies -- Methods for Comparing Two Treatments for a Dichotomous Outcome for a Two-Period Design with Treatment Switching of Control Group Period 1 Non-Responders -- Regression-based estimation of optimal adaptive treatment strategies: Key methods -- Vaccine Disease-Prevention Efficacy Studies: Traditional Approaches and New Frontiers -- Covariate Adjustment in Analyzing Randomized Clinical Trials: Approaches, Software, and Application -- Joint correlated responses and feedback effect with time-dependent covariates -- Distributions and Their Approximations for P-Values.

The Deming Conference on Applied Statistics has long been deemed an influential event in the biostatistics and biopharmaceutical profession. It provides learning experience on recent developments in statistical methodologies in biopharmaceutical applications and FDA regulations. This book honors 80 years of contributions and dedication of the Deming Conference in biostatistics, and biopharmaceutical clinical trial methodology and applications. All chapters are contributed by world-class and prominent Deming speakers, who've contributed their cutting-edge research and developments to the community. Volume 2 covers Biomarkers in Drug Development, Time-To-Event Data Analysis and Methods, and emerging development in biopharmaceutical biostatistics. This book aims to booster research, education, and training in biostatistics and in biopharmaceutical research and development.

ISBN: 9783031659379

Standard No.: 10.1007/978-3-031-65937-9doiSubjects--Topical Terms:

724498
Clinical trials.

LC Class. No.: R853.C55

Dewey Class. No.: 615.50724

Biostatistics in biopharmaceutical research and development.. Volume 2,. Clinical trial analysis
LDR:03313nmm a2200337 a 4500 001 2389243
003 DE-He213
005 20241225115243.0
006 m d
007 cr nn 008maaau
008 250916s2024 sz s 0 eng d
020 $a 9783031659379 $q (electronic bk.)
020 $a 9783031659362 $q (paper)
024 7 $a 10.1007/978-3-031-65937-9 $2 doi
035 $a 978-3-031-65937-9
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.C55
072 7 $a PBT $2 bicssc
072 7 $a MAT029000 $2 bisacsh
072 7 $a PBT $2 thema
082 0 4 $a 615.50724 $2 23
090 $a R853.C55 $b B616 2024
245 0 0 $a Biostatistics in biopharmaceutical research and development. $n Volume 2, $p Clinical trial analysis $h [electronic resource] / $c edited by Ding-Geng Chen.
246 3 0 $a Clinical trial analysis
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a xviii, 517 p. : $b ill., digital ; $c 24 cm.
505 0 $a Statistical Challenges in the Analysis of Biomarker Data -- 2. Evaluating Predictive Accuracy of Prognostic Model for Censored Time-to-Event Data Analysis in Clinical Trials -- Statistical Methods for Accommodating Immortal Time: A Selective Review and Comparison -- Variable selection for partially functional additive Cox Model with interval-censored failure time data -- A Bayesian proportional hazards model to predict patient recruitment in multicenter clinical trials -- GET MORE INFORMATION FROM RECURRENT EVENTS DATA -- Introduction to Patient Preference Studies -- Machine Learning for Precision Medicine and Humanized AI for Future Healthcare -- The Statistical Evaluation of Surrogate Endpoints in Clinical Trials -- Treatment Effect Estimation Using Data from Observational and Non-Randomized Studies -- Methods for Comparing Two Treatments for a Dichotomous Outcome for a Two-Period Design with Treatment Switching of Control Group Period 1 Non-Responders -- Regression-based estimation of optimal adaptive treatment strategies: Key methods -- Vaccine Disease-Prevention Efficacy Studies: Traditional Approaches and New Frontiers -- Covariate Adjustment in Analyzing Randomized Clinical Trials: Approaches, Software, and Application -- Joint correlated responses and feedback effect with time-dependent covariates -- Distributions and Their Approximations for P-Values.
520 $a The Deming Conference on Applied Statistics has long been deemed an influential event in the biostatistics and biopharmaceutical profession. It provides learning experience on recent developments in statistical methodologies in biopharmaceutical applications and FDA regulations. This book honors 80 years of contributions and dedication of the Deming Conference in biostatistics, and biopharmaceutical clinical trial methodology and applications. All chapters are contributed by world-class and prominent Deming speakers, who've contributed their cutting-edge research and developments to the community. Volume 2 covers Biomarkers in Drug Development, Time-To-Event Data Analysis and Methods, and emerging development in biopharmaceutical biostatistics. This book aims to booster research, education, and training in biostatistics and in biopharmaceutical research and development.
650 0 $a Clinical trials. $3 724498
650 0 $a Biometry. $3 531975
650 0 $a Biopharmaceutics. $3 690368
650 1 4 $a Statistics. $3 517247
650 2 4 $a Biostatistics. $3 1002712
650 2 4 $a Clinical Research. $3 3531315
650 2 4 $a Methodology of Data Collection and Processing. $3 3598081
650 2 4 $a Survey Methodology. $3 3602229
650 2 4 $a Public Health. $3 624351
700 1 $a Chen, Ding-Geng. $3 1097388
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-65937-9
950 $a Medicine (SpringerNature-11650)